Literature DB >> 14499979

Urinary incontinence as a worldwide problem.

V A Minassian1, H P Drutz, A Al-Badr.   

Abstract

OBJECTIVES: This paper reviews the literature on the prevalence of urinary incontinence (UI) and demonstrates its impact as a worldwide problem.
METHODS: A MEDLINE search was performed to review population-based studies in English. Studies were grouped according to demographic variables and type of incontinence. Risk factors, help-seeking behavior, and quality of life measures were analyzed.
RESULTS: The median prevalence of female UI was 27.6% (range: 4.8-58.4%) and prevalence of significant incontinence increased with age. The commonest cause of UI was stress (50%), then mixed (32%) and finally urge (14%). Risk factors included parity, obesity, chronic cough, depression, poor health, lower urinary tract symptoms, previous hysterectomy, and stroke. Although quality of life was affected, most patients did not seek help.
CONCLUSION: UI is a prevalent cross-cultural condition. Future studies should rely on universally accepted standardized definitions to produce meaningful evidence-based conclusions, as well as project the costs of this global healthcare problem.

Entities:  

Mesh:

Year:  2003        PMID: 14499979     DOI: 10.1016/s0020-7292(03)00220-0

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  128 in total

1.  Parity is not associated with urgency with or without urinary incontinence.

Authors:  Annemarie G Hirsch; Vatche A Minassian; Anne Dilley; Jennifer Sartorius; Walter F Stewart
Journal:  Int Urogynecol J       Date:  2010-05-11       Impact factor: 2.894

2.  The effect of weight loss on changes in health-related quality of life among overweight and obese women with urinary incontinence.

Authors:  Angela Marinilli Pinto; Leslee L Subak; Sanae Nakagawa; Eric Vittinghoff; Rena R Wing; John W Kusek; William H Herman; Delia Smith West; Miriam Kuppermann
Journal:  Qual Life Res       Date:  2011-12-10       Impact factor: 4.147

3.  The greatest taboo: urinary incontinence as a source of shame and embarrassment.

Authors:  Ksenia Elenskaia; Karin Haidvogel; Christine Heidinger; Daniela Doerfler; Wolfgang Umek; Engelbert Hanzal
Journal:  Wien Klin Wochenschr       Date:  2011-09-22       Impact factor: 1.704

Review 4.  Sacral nerve modulation in overactive bladder.

Authors:  John A Occhino; Steven W Siegel
Journal:  Curr Urol Rep       Date:  2010-09       Impact factor: 3.092

5.  Short-term Uresta efficacy (SURE) study: a randomized controlled trial of the Uresta continence device.

Authors:  Danny Lovatsis; Carolyn Best; Phaedra Diamond
Journal:  Int Urogynecol J       Date:  2016-07-20       Impact factor: 2.894

6.  Urinary incontinence among women-which personal and professional relations are involved? A population-based study.

Authors:  Isabella Raasthøj; Sandra Elnegaard; Marianne Rosendal; Dorte Ejg Jarbøl
Journal:  Int Urogynecol J       Date:  2018-11-05       Impact factor: 2.894

7.  Duloxetine Treatment of Stress Urinary Incontinence in Women Does Not Induce Mania or Hypomania.

Authors:  Lars Viktrup; David G Perahia; Andre Tylee
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

8.  Incidence of stress urinary incontinence among women in Turkey.

Authors:  Aydan Biri; Elif Durukan; Işil Maral; Umit Korucuoğlu; Hasan Biri; Bülent Týraş; Mehmet Ali Bumin
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-04-21

Review 9.  Mixed urinary incontinence: international urogynecological association research and development committee opinion.

Authors:  Dorothy Kammerer-Doak; Diaa E E Rizk; Olanrewaju Sorinola; Wael Agur; Sharif Ismail; Tony Bazi
Journal:  Int Urogynecol J       Date:  2014-08-05       Impact factor: 2.894

Review 10.  Coadministration of low-dose serotonin/noradrenaline reuptake inhibitor (SNRI) duloxetine with α 2-adrenoceptor blockers to treat both female and male mild-to-moderate stress urinary incontinence (SUI).

Authors:  C Alberti
Journal:  G Chir       Date:  2013 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.